StemCells Inc Share Price Nasdaq
Stocks
US85857R2040
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Market Cap | 96.72M 83.18M 78.23M 71.41M 134M 9.15B 134M 928M 359M 4.68B 363M 355M 14.92B | P/E 2026 * |
-4.6x | P/E 2027 * | -4.19x |
|---|---|---|---|---|---|
| Enterprise Value | 96.72M 83.18M 78.23M 71.41M 134M 9.15B 134M 928M 359M 4.68B 363M 355M 14.92B | EV / Sales 2026 * |
60.5x | EV / Sales 2027 * | 11x |
| Free-Float |
100% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : StemCells Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Harel Gadot
CEO | Chief Executive Officer | 54 | 01/08/1988 |
Rachel Vaknin
DFI | Director of Finance/CFO | 47 | 31/03/2022 |
Michal Ahuvia
COO | Chief Operating Officer | - | 20/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Harel Gadot
CHM | Chairman | 54 | 31/12/2012 |
Scott Burell
BRD | Director/Board Member | 61 | 27/11/2016 |
Martin Madden
BRD | Director/Board Member | 65 | 05/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.70% | -2.35% | -1.05% | +16.62% | 48.41B | |
| -0.40% | +2.16% | +418.57% | +554.47% | 45.01B | |
| -1.42% | +2.52% | +42.67% | +22.27% | 44.07B | |
| -1.22% | -0.37% | +4.82% | +84.42% | 40.73B | |
| -0.96% | -1.38% | +15.75% | +45.91% | 33.21B | |
| -0.21% | +2.86% | - | - | 17.77B | |
| -0.35% | -0.45% | +21.42% | +117.63% | 16.5B | |
| -0.59% | -0.61% | +11.26% | +31.27% | 14.45B | |
| -1.65% | +0.09% | +75.93% | +41.15% | 13.77B | |
| Average | -0.69% | +0.29% | +73.67% | +114.22% | 30.44B | |
| Weighted average by Cap. | -0.62% | -0.02% | +89.60% | +135.34% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.6M 1.37M 1.29M 1.18M 2.21M 151M 2.21M 15.33M 5.93M 77.43M 6M 5.87M 247M | 8.8M 7.57M 7.12M 6.5M 12.15M 832M 12.19M 84.4M 32.62M 426M 33.05M 32.33M 1.36B |
| Net income | -21.13M -18.17M -17.09M -15.6M -29.18M -2B -29.28M -203M -78.34M -1.02B -79.36M -77.63M -3.26B | -23.92M -20.57M -19.35M -17.66M -33.04M -2.26B -33.14M -229M -88.69M -1.16B -89.84M -87.88M -3.69B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
